Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis
NCT ID: NCT02553798
Last Updated: 2021-08-25
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
564 participants
INTERVENTIONAL
2015-08-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Glycopyrronium in Axillary Hyperhydrosis
NCT02530281
Investigation of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in Subjects With Axillary Hyperhidrosis
NCT03037788
Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topical Umeclidinium in Primary Axillary Hyperhidrosis
NCT02563899
Safety and Efficacy of an Anticholinergic Agent for Treatment of Primary Axillary Hyperhidrosis
NCT02193139
Long Term Results of the Use of Oxybutynin for the Treatment of Hyperhidrosis
NCT01956591
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Glycopyrronium
Glycopyrronium Topical Wipes
Glycopyrronium Topical Wipes
Glycopyrronium Topical Wipes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Glycopyrronium Topical Wipes
Glycopyrronium Topical Wipes
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or females
Exclusion Criteria
* Male with a history of urinary retention requiring catheterization due to prostatic hypertrophy or severe obstructive symptoms of prostatic hypertrophy
* Any other condition which, in the judgement of the Investigator, would put the subject at unacceptable risk for participation in the study
9 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Journey Medical Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lynne Deans, MT
Role: STUDY_DIRECTOR
Dermira, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Coastal Medical Research Group LLC
Mobile, Alabama, United States
Northwest Arkansas Clinical Trials Center, PLLC
Rogers, Arkansas, United States
California Dermatology & Clinical Research Institute
Encinitas, California, United States
Dermatology Research Associates
Los Angeles, California, United States
Therapeutics Clinical Research
San Diego, California, United States
Clinical Science Institute
Santa Monica, California, United States
Colorado Medical Research Center, Inc
Denver, Colorado, United States
Skin Care Research, Inc.
Boca Raton, Florida, United States
Study Protocol, Inc
Boynton Beach, Florida, United States
International Dermatology Research, Inc.
Miami, Florida, United States
Tory Sullivan, MD
North Miami Beach, Florida, United States
Research Institute of the Southeast
West Palm Beach, Florida, United States
Shideler Clinical Research Center
Carmel, Indiana, United States
The Indiana Clinical Trials Center, PC
Plainfield, Indiana, United States
Prairie Health and Wellness
Wichita, Kansas, United States
Lawrence J. Green M.D., LLC
Rockville, Maryland, United States
Zel Skin & Laser Specialist
Edina, Minnesota, United States
MediSearch Clinical Trials
Saint Joseph, Missouri, United States
St. Louis University Dermatology
St Louis, Missouri, United States
Meridian Clinical Research
Omaha, Nebraska, United States
Academic Dermatology Associates
Albuquerque, New Mexico, United States
Schweiger Dermatology Group
New York, New York, United States
Skin Search of Rochester, Inc
Rochester, New York, United States
Oregon Dermatology and Research Center
Portland, Oregon, United States
Dermatology and Laser Center of Charleston, PA
Charleston, Pennsylvania, United States
Rivergate Dermatology Research Center, PLLC
Goodlettsville, Tennessee, United States
Clinical Research Associates, Inc
Nashville, Tennessee, United States
DermResearch
Austin, Texas, United States
J & S Studies, Inc.
College Station, Texas, United States
Modern Research Associates, PLLC
Dallas, Texas, United States
The University of Texas Dermatology Clinical Research Center
Houston, Texas, United States
Austin Institute for Clinical Research
Pflugerville, Texas, United States
ACRC Trials
Plano, Texas, United States
Texas Dermatology and Laser Specialists
San Antonio, Texas, United States
Dermatology Research Center, Inc.
Salt Lake City, Utah, United States
Jordan Valley Dermatology Center, LLC
West Jordan, Utah, United States
Charlottesville Medical Research
Charlottesville, Virginia, United States
Virginia Clinical Research, Inc.
Norfolk, Virginia, United States
Dermatology Associates
Seattle, Washington, United States
Premier Clinical Research
Spokane, Washington, United States
Klinik für Dermatologie, Venerologie und Allergologie Allergie-Centrum-Charité
Berlin, , Germany
Pro DERMA im Hautzentrum Dulmen
Dülmen, , Germany
Medical Practice and Derma-Study-Center Friedrichshafen GmbH
Friedrichshafen, , Germany
SRH Wald-Klinikum Gera GmbH
Gera, , Germany
Hautarztpraxis
Glückstadt, , Germany
Tagesklinik DermaKiel
Kiel, , Germany
Dermatolosche Gemeinschaftspraxis
Mahlow, , Germany
Gemeinschaftspraxis Weber & Cranic
Schweinfurt, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Glaser DA, Hebert AA, Nast A, Werschler WP, Green L, Mamelok RD, Quiring J, Drew J, Pariser DM. A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis. Am J Clin Dermatol. 2019 Aug;20(4):593-604. doi: 10.1007/s40257-019-00446-6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DRM04-HH06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.